Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 08:33:26 +0200Fri, 24 May 2024 16:00:00 +0200Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation: 13/07/2011, Revision: 34, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/benlystaHuman medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation: 13/07/2011, Revision: 34, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/benlystaFri, 24 May 2024 16:00:00 +0200Human medicineBenlysta-H-C-2015-PSUV-19 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisationhttps://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500159823_en.pdfBenlysta-H-C-2015-PSUV-19 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisationhttps://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500159823_en.pdfTue, 21 Jan 2014 01:00:00 +0100Human medicine